The European Commission has published an implementation roadmap and progress indicators for Europe’s Beating Cancer Plan to monitor developments on the ten flagship initiatives as well as its other actions.

On 7–8th of October, Vision Zero Cancer together with OECD Observatory of Public Sector Innovation met together with around 60 participants, speakers, and panellists for a Mission-oriented Innovation Bootcamp – a journey into the intersection of mission-oriented innovation and personalised medicine.

Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with SciLifeLab, public sector authorities, regions, healthcare, academia, industry and patient associations to create an innovation milieu that facilitates the introduction of more precise prevention and treatment in cancer care.

To reduce the burden of cancer, improve outcomes and the quality of care for cancer patients, European Cancer organization convene oncology professionals and patients to agree policy, advocate for positive change and be the united voice of the European cancer community.

ECHoS is an European project, funded by Horizon Europe Programme, that aims to support the implementation of the Cancer Mission activities in all Member State and Associated Country (MS/AC) through the establishment and development of National Cancer Mission Hubs (NCMHs) operating at national, regional, and local levels.

In the latest issue of Oncology in Sweden, a number of people from Vision Zero Cancer were interviewed about the beginning, the vision, how it is going to become reality and the importance of collaboration and inclusiveness to make a change.

Lung cancer accounts for one in five deaths worldwide. The past few years have seen considerable advances in treatment for lung cancer, yet the prognosis remains low. Lung cancer causes symptoms that come up late in the course of the disease and assessments are complicated. This means that half of the patients have a spread disease at diagnosis.

The aim of Europe’s Beating Cancer Plan is to tackle the entire disease pathway. Over the coming years, it will focus on research and innovation, tap into the potential that digitalisation and new technologies offer, and mobilise financial instruments to support Member States.

Are milieus like Vision Zero Cancer a good way to accelerate innovation? At Stockholm School of Economics, doctoral student John-Erik Bergkvist is researching this – the methodology for building a vision-driven innovation milieu.

Swecare creates meeting places where the Swedish life science sector can strengthen their international relationships

Around 60 experts gathered during the virtual experience exchange between Sweden and Russia as part of a collaboration between the Association of Oncologists of Russia and Vision Zero cancer, aided by Business Sweden and the Embassy of Sweden to the Russian Federation.

One size fits all is no longer applicable. Precision medicine has made several advancements in recent years. Rapid development in research and technology is creating conditions for a transformation of the system. With these developments come challenges and consequences – but which ones?

More and more patients need radiotherapy. But radiation therapy treatment is an area where research in Sweden has gone from leading to lagging behind internationally. How do we reverse the trend? How do we ensure that radiation therapy research continues to develop and become even better so that more patients survive and can live a better life with less side effects?

To transform cancer from a deadly to a curable or chronic disease it is crucial to improve the precision in cancer treatment and follow-up of individual patients' cancer disease. The Partnership for Precision Medicine in Cancer and Vision Zero Cancer are joining forces to accelerate research into precision medicine, with the aim to benefit every cancer patient.

Europe’s Beating Cancer Plan is a political commitment to turn the tide against cancer and another stepping stone towards a strong European Health Union and a more secure, better-prepared and more resilient EU.

Improving people's living habits is a prerequisite for achieving the vision of zero, which is why we gathered a number of actors from different parts of society for a workshop on prevention related to lung cancer.

Lung cancer is today the leading cause of death in Sweden. The earlier that lung cancer is detected, the greater are the chances of survival. A national screening programme has been brought to attention, but much needs to be resolved before we are there. Around 70 participants met digitally during a workshop on early detection and diagnosis of lung cancer hosted by Vision Zero cancer.

Research on cancer, and the standardised care pathways, are mostly based on set diagnoses and are mainly based on research done in secondary care. This became clear to General Practitioners Elinor Nemlander and Eliya Abedi – Sweden needs more primary care-focused research, based on symptoms and not diagnoses.

Fourteen. That's how many times, Mia Rajalin visited primary care before she received the chest X-ray that showed the tumor. And the X-ray referral was sent with hesitation – she was too young and had never smoked a cigarette.

The Lung Cancer Association wants to change lung cancer care. Especially in the case of early detection, where many other countries have already introduced tools and methods to support healthcare. But in Sweden it takes too long, says Karin Liljelund, the association's vice chairman. And lung cancer does not wait.